15th – 17th October WFIP at The Festival of Biologics, Basel
The president of WFIP, Mary Lynne Van Poelgeest-Pomfret, was present in Basel Switzerland representing WFIP. The Festival was an excellent opportunity for WFIP to enforce its mission, considering that the Festival hosted four exceptional conferences, the European Antibody Congress, the World Immunotherapy Congress, the World Biosimilar Congress and the Clinical Trials World Congress.
During the Festival, Mary Lynne Van Poelgeest-Pomfret spoke on “Real World Evidence”, taking the opportunity also to point out the necessity of relying on RWE so as to improve all aspects of patient management.
The presentation was well received, more so because the issue of considering the patient’s point of view is still at an early stage. The focus, and to a point rightly so, has so far been on obtaining positive clinical results when considering a pathology. Ms Van Poelgeest-Pomfret’s presentation highlighted the fact that the patient, who after all is the principal actor, has so far been put in second place when considering the perspective from which a pathology is considered.
The Festival was also an excellent opportunity for the president to advocate for WFIP during the numerous social moments, and as a result, she has brought home contacts who are enthused about what the association has done so far, and where it is going.
Day 3 was the clou moment, when the presentation (attached here) was given, and the Session on Real World Evidence which was chaired by Yvonne Brady, CEO of EVB Sport, with whom WFIP has an excellent rapport.
A few words on the Festival. It was a stage on which industry leaders met, discussed and showcase their work in the biologics, biopharma and immunotherapy fields, among others. The speakers belonged to various fields going from big pharma, biotech, academia, regulatory bodies, to investor groups, and associations, and they all took the opportunity to discuss topics which embody the key challenges within their industries, new data, case studies and research.
The concluding impression is definitely positive. There is room for action, WFIP is on the route to becoming a leader in the promotion for patient awareness from all points of views, be it institutions, public health systems, and of course the patient.
The attention is now on future events, certain that they will bring home results which are just as positive.